Jeetinder Singh Mahal - Apr 7, 2022 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Chief Operating Officer, Chief Financial Officer and Corporate Secretary
Signature: /s/ Jeet Mahal
Stock symbol: JSPR
Transactions as of: Apr 7, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/8/2022, 04:01 PM
Previous filing: Mar 23, 2022
Next filing: Oct 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JSPR	Stock Option (right to buy)	Award	$0	+48.4K		$0.00	48.4K	Apr 7, 2022	Voting Common Stock	48.4K	$3.12	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on March 21, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Remarks:

Chief Operating Officer, Chief Financial Officer and Corporate Secretary